Mosapride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I8MFJ1C0BY. European Medicines Agency schedules Mosapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09074MIG. Mosapride generally arises in the molecular formula C21H25CLFN3O3. The term MOSAPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, no, 3 1992, list 32.) MOSAPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mosapride under HS 29349990 and SITC 51579. As of Q4 2014, MOSAPRIDE remains the US FDA Preferred Term for this commodity. Mosapride bears US NLM identifiers UMLS ID C0526501 and NCI Concept Code C66204. SMILES: Clc1cc(C(=O)NCC2OCCN(C2)Cc2ccc(F)cc2)c(OCC)cc1N.